DK0497886T3 - Assay, der omfatter blandede immunoglobuliner til påvisning af rheumatoide faktorer - Google Patents

Assay, der omfatter blandede immunoglobuliner til påvisning af rheumatoide faktorer

Info

Publication number
DK0497886T3
DK0497886T3 DK90916889.0T DK90916889T DK0497886T3 DK 0497886 T3 DK0497886 T3 DK 0497886T3 DK 90916889 T DK90916889 T DK 90916889T DK 0497886 T3 DK0497886 T3 DK 0497886T3
Authority
DK
Denmark
Prior art keywords
assay
detection
rheumatoid factors
immunoglobulins
mixed
Prior art date
Application number
DK90916889.0T
Other languages
English (en)
Inventor
Richard Weisbart
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0497886T3 publication Critical patent/DK0497886T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK90916889.0T 1989-10-23 1990-10-03 Assay, der omfatter blandede immunoglobuliner til påvisning af rheumatoide faktorer DK0497886T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42547489A 1989-10-23 1989-10-23
US51724690A 1990-05-01 1990-05-01

Publications (1)

Publication Number Publication Date
DK0497886T3 true DK0497886T3 (da) 1996-06-24

Family

ID=27026697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90916889.0T DK0497886T3 (da) 1989-10-23 1990-10-03 Assay, der omfatter blandede immunoglobuliner til påvisning af rheumatoide faktorer

Country Status (8)

Country Link
EP (1) EP0497886B1 (da)
JP (1) JP2905595B2 (da)
AT (1) ATE135821T1 (da)
CA (1) CA2070411A1 (da)
DE (1) DE69026106T2 (da)
DK (1) DK0497886T3 (da)
ES (1) ES2085917T3 (da)
WO (1) WO1991005873A1 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484727A (fr) * 1966-04-19 1967-06-16 Réactif immunologique et son procédé d'obtention
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
US4361647A (en) * 1980-05-22 1982-11-30 Palo Alto Medical Research Foundation Sandwich immunoassay and compositions for use therein
US4434227A (en) * 1982-02-08 1984-02-28 Abbott Laboratories Immunoassay for class specific immunoglobulin antibodies
JPH01296163A (ja) * 1987-12-28 1989-11-29 Univ California IgGリウマトイド因子試験

Also Published As

Publication number Publication date
EP0497886A4 (en) 1992-10-14
CA2070411A1 (en) 1991-04-24
EP0497886B1 (en) 1996-03-20
WO1991005873A1 (en) 1991-05-02
DE69026106T2 (de) 1996-10-24
ES2085917T3 (es) 1996-06-16
ATE135821T1 (de) 1996-04-15
JP2905595B2 (ja) 1999-06-14
EP0497886A1 (en) 1992-08-12
JPH05501919A (ja) 1993-04-08
DE69026106D1 (de) 1996-04-25

Similar Documents

Publication Publication Date Title
DE3788397T3 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
ATE315228T1 (de) Immunoassay zum bestimmen von bnp
DK520087A (da) Fremgangsmaade til oprensning af rekombinerede proteiner samt produkter deraf
DE3685937D1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DK0449269T3 (da) Fremgangsmåde til påvisning af proteiner indeholdende phosphoryleret tyrosin
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
ES2070820T3 (es) Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DK603087A (da) Immunokemisk metod tilbestemmelse af stabilt glycosyleret haemoglobin
DE68907620D1 (de) Dichtungspruefverfahren von kunststoff-behaeltern.
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
ATE102357T1 (de) Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz.
DK0497886T3 (da) Assay, der omfatter blandede immunoglobuliner til påvisning af rheumatoide faktorer
ES550768A0 (es) Procedimiento para la determinacion especifica de alfa-ami- lasa
KR910001377A (ko) Hiv에 대한 항체 면역검정법
DE3874741D1 (de) Immunassay-verfahren.
NO173831C (no) Nye monoklonale antistoffer mot IFN-omega, hybridomer til fremstilling derav og anvendelse for rensing samt paavisning eller kvantitativ bestemmelse av IFN-omega, og sett for bruk ved paavisningen
GR3030212T3 (en) Platelet activating factor antagonists.
ES516244A0 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
DK276185D0 (da) Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
ES2070833T3 (es) Procedimiento para la determinacion cuantitativa de proteinas del suero en liquidos corporales y agente para realizar el procedimiento.